Successful treatment of a woman with relapsing neuromyelitis optica by interferon beta

Neurological Sciences

Volumn 33, Issue 4, 2012, Pages 911-913

  Xu, Yan ^a   Zhang, Yao ^a   Ye, Jing ^b   Peng, Bin ^a   Wang, Jian Ming ^a   Cui, Li Ying ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anti MOG IgG; AQP4 IgG; Beta interferon; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4; AZATHIOPRINE; BETA1A INTERFERON; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADULT; ANTIBODY BLOOD LEVEL; AREFLEXIA; ARTICLE; CASE REPORT; CONSTIPATION; DRUG MEGADOSE; EMBRYO; FEMALE; HUMAN; HUMAN CELL; LIMB WEAKNESS; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESTHESIA; RELAPSE; URINE RETENTION; VISUAL ACUITY;

AGED; AQUAPORIN 4; BRAIN; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; NEUROMYELITIS OPTICA; SPINAL CORD;

EID: 84863990078     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0849-0     Document Type: Article

References (15)

1. Wingerchuk DM (2007) Diagnosis and treatment of neuromyelitis optica. Neurologist 13:2-11 (Pubitemid 46095579)
2. Palace J, Leite MI, Nairne A, Vincent A (2010) Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin-4 antibody titers. Arch Neurol 67:1016-1017
3. Saida T, Tashiro K, Itoyama Y, Sato T, Ohashi Y, Zhao Z et al (2005) Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 64:621-630 (Pubitemid 40261889)
4. Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S (2010) Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol 17:672-676
5. Tanaka M, Tanaka K, Komori M (2009) Interferon-b1b treatment in neuromyelitis optica. Eur Neurol 62:167-170
6. Axtell RC, Raman C, Steinman L (2011) Interferon-b exacerbates Th17-mediated inflammatory disease. Trends Immunol 32: 272-277
7. Rep MH, Schrijver HM, van Lopik T, Hintzen RQ, Roos MT, Ader HJ et al (1999) Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferongamma producing T cells in MS patients. J Neuroimmunol 96: 92-100 (Pubitemid 29179749)
8. Rudick RA, Ransohoff RM, Lee JC, Peppler R, Yu M, Mathisen PM et al (1998) In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology 50: 1294-1300 (Pubitemid 28240342)
9. Furlan R, Bergami A, Lang R, Brambilla E, Franciotta D, Martinelli V et al (2000) Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4. J Neuroimmunol 111:86-92
10. Haase CG, Schmidt S (2001) Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica. Neurosci Lett 307:131-133 (Pubitemid 32568392)
11. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N et al (2009) Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39:87-90
12. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM et al (2008) Neuromyelitis optica and nonorgan- specific autoimmunity. Arch Neurol 65:78-83
13. Fukazawa T, Hamada T, Kikuchi S, Sasaki H, Tashiro K, Maguchi S (1996) Antineutrophil cytoplasmic antibodies and the optico-spinal form of multiple sclerosis in Japan. J Neurol Neurosurg Psych 61:203-204 (Pubitemid 26264335)
14. Chou CH, Chou FC, Tourtellotte WW, Kibler RF (1984) Devic's syndrome: antibody to glial fibrillary acidic protein in cerebrospinal fluid. Neurology 34:86-88 (Pubitemid 14220918)
15. Lalive PH, Menge T, Barman I, Cree BA, Genain CP (2006) Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 67:176-177 (Pubitemid 44305492)